Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Dr. Norwood's analysis highlights the need for careful patient selection and strategic hair transplant design to create a natural-looking hair density.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair graying is caused by the loss of pigment cells due to poor maintenance of stem cells in the hair follicle.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

Minoxidil and finasteride work best for hair loss; more research needed.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Found 32 genes linked to male baldness, affecting hair growth and stress-related pathways.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Finasteride helps hair growth but may cause sexual side effects and depression.